Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma
Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma
Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
5. <strong>QST</strong> in patients with tendinopathy<br />
0<br />
The outcome of the present study showed a large variability in different threshold values<br />
as measured with <strong>QST</strong>. Although <strong>QST</strong> is the golden standard to measure somatosensory<br />
aberrations its success depends on the participant’s perceptions and concentration<br />
which may induce heterogeneity. Furthermore, earlier studies found hypesthesia on the<br />
affected side in some athletes this may be a subgroup and explain the large variability<br />
within the groups (Jensen et al 2008; van Wilgen & Keizer 2011).<br />
Further studies are needed to confirm whether the assessment for mechanical pain<br />
thresholds (myelinated Aδ-fibres) using standardized pinprick devices is adding to the<br />
clinical diagnosis of PT. A limitation of this study was that the diagnosis PT was based<br />
only on clinical examination by a sport medicine physician or sport physical therapist;<br />
no additional imaging techniques were used to investigate structural changes of the<br />
tendon which increases the likelihood of the diagnosis. On the other hand clinicians<br />
excluded patients with other knee pathology such as patella femoral pain syndrome,<br />
intra-articular pathology and ligament injuries. Furthermore, in the analyses of <strong>QST</strong><br />
data mostly z-score transformations of data are used to identify sensory abnormalities<br />
with respect to controls (Rolke et al 2006a). Since z-score transformation and their<br />
interpretation is highly dependent on reference values we could not include such<br />
transformation due to the low numbers of participants, therefore in future studies larger<br />
groups should be included. Despite the fact that manual pressure pain thresholds for the<br />
clinical diagnose of PT has been used, the <strong>QST</strong> results for PPT showed no significant<br />
differences between the groups. The reason may be that we included patients with a<br />
long history of PT with pain evoked by sports activities. Furthermore all patients were<br />
measured on the same spot at the patella tendon and not on the most painful spot which<br />
is used in the clinical practice. In another study we measured athletes with PT and used<br />
an algometer (MicroFET2 Biometrics BV). This algometer was shaped like a fingertip<br />
an applied on the most painful spot of the patella tendon. In this study lower PPT’s<br />
and significant differences between patients and controls were found (Kregel et al.,<br />
submitted). Looking back at this study, a similar approach would have probably yielded<br />
more pronounced differences between the patient group and the control group in our<br />
study. Another limitation was that we recruited healthy controls through advertisements<br />
on websites, this procedure might have led to selection bias. Furthermore, we did not<br />
take into account if athletes participated in sports activities the day before the study,<br />
this may have interfered with the results of the study.<br />
4.1. Conclusion<br />
This is the first study investigating somatosensory aberrations in chronic patellar<br />
tendinopathy using a standardized <strong>QST</strong> protocol. Results of this explorative study should<br />
be interpreted as such as sensitisation might play an important role in the contribution<br />
of pain during and after sports activity in PT patients.